Tranquis Therapeutics Announces Participation in March Investor Conferences
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Tranquis Therapeutics, a clinical-stage private immuno-neurology company developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases, today announced that members of its management team will participate in the following investor conferences in March 2022: Stifel CNS Days Date: Tuesday, March 29,...
